Last reviewed · How we verify
NCT06163807: MEGA
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry
trial testing Antiasthmatic in Chronic Asthma in 1,200 participants. Currently enrolling.
2 June 2026
Quick facts
| Lead sponsor | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,200 |
| Start date | 1 February 2025 |
| Primary completion | 2 June 2026 |
| Estimated completion | 2 June 2026 |
| Sites | 8 locations across Spain |
Drugs / interventions tested
- Antiasthmatic — full drug profile →
Conditions studied
- Chronic Asthma — all drugs for Chronic Asthma →
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz — full company profile →
Who can join
Adults 18 to 80, any sex, with Chronic Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary objective \- To study the stability of different phenotypes and endotypes of asthma at 3, 5, and 7 years of follow-up and - in MEGA COHORT and in patients on biologic treatment Secondary objective(s) * To study biomarkers variation post-treatment in patients with and without Nasal Polyposis * To demonstrate the existence of different subtypes of eosinophils that may be phenotypically and functionally heterogeneous * To increase the number of patients in the cohort on biologic treatment to reach at least 900 (400 over the current cohort).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06163807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Asthma
Currently open trials in the same condition.
- NCT06457009 — Impact of Multi-Component Intervention on Suspected Asthma Population · NA · active not recruiting
- NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting
- NCT04395937 — SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Tra · NA · recruiting
Other Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials
Trials by the same sponsor.
- NCT07416760 — Analysis of the Composition of the Intestinal Microbiota in Patients Post-intestinal Anastomosis · recruiting
- NCT07115680 — Where Did the Authors Work When They Conducted Their Clinical Pharmacology Studies? · completed
- NCT07003308 — Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis · NA · recruiting
- NCT06968000 — Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperat · Phase 1, PHASE2 · recruiting
- NCT06667245 — Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06163807 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Last refreshed: 30 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing